Recurrent lymphangioleiomyomatosis in a lung allograft with COVID-19: autopsy case report and literature review

[1]  J. Jougon,et al.  COVID-19 in Lung Transplant Recipients. , 2020, Transplantation.

[2]  M. Barrecheguren,et al.  COVID-19 in lung transplant recipients: A multicenter study , 2020, American Journal of Transplantation.

[3]  A. Borczuk,et al.  COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City , 2020, Modern Pathology.

[4]  J. Myers,et al.  Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD , 2020, Histopathology.

[5]  A. Mehta,et al.  Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation. , 2016, World journal of transplantation.

[6]  H. Date,et al.  Lung Transplantation for Lymphangioleiomyomatosis in Japan , 2016, PloS one.

[7]  C. Burger.  Efficacy and safety of sirolimus in lymphangioleiomyomatosis. , 2011, The New England journal of medicine.

[8]  J. Krischer,et al.  Efficacy and safety of sirolimus in lymphangioleiomyomatosis. , 2011, The New England journal of medicine.

[9]  H. Popper,et al.  European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis , 2010, European Respiratory Journal.

[10]  S. Toyooka,et al.  Sirolimus amelioration of clinical symptoms of recurrent lymphangioleiomyomatosis after living-donor lobar lung transplantation. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  G. Beck,et al.  Lung transplantation in the management of patients with lymphangioleiomyomatosis: baseline data from the NHLBI LAM Registry. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[12]  T. Bando,et al.  Recurrent lymphangioleiomyomatosis after living-donor lobar lung transplantation. , 2006, Transplantation proceedings.

[13]  A. Geha,et al.  The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  J. Galvin,et al.  From the archives of the AFIP: lymphangioleiomyomatosis: radiologic-pathologic correlation. , 2005, Radiographics : a review publication of the Radiological Society of North America, Inc.

[15]  J. Testa,et al.  Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. , 2003, American journal of respiratory and critical care medicine.

[16]  W. Travis,et al.  Prognostic Significance of Pulmonary Lymphangioleiomyomatosis Histologic Score , 2001, The American journal of surgical pathology.

[17]  G. Patterson,et al.  Lung transplantation for lymphangioleiomyomatosis. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  H. Dienemann,et al.  Lymphangioleiomyomatosis: recurrence after single lung transplantation. , 1997, Human pathology.

[19]  B. Griffith,et al.  Lung transplantation for respiratory failure resulting from systemic disease. , 1997, The Annals of thoracic surgery.

[20]  R. Speich,et al.  Lung transplantation for lymphangioleiomyomatosis. , 1996, The New England journal of medicine.

[21]  E. Trulock,et al.  Lymphangiomyomatosis recurrence in the allograft after single-lung transplantation. , 1995, American journal of respiratory and critical care medicine.

[22]  B. Griffith,et al.  Lymphangioleiomyomatosis: recurrence after lung transplantation. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  G. Primo,et al.  COMBINED HEART-AND-LUNG TRANSPLANTATION FOR LYMPHANGIOLEIOMYOMATOSIS , 1984, The Lancet.

[24]  J. Qu,et al.  Identification of driver genes and somatic mutations in cell‐free DNA of patients with pulmonary lymphangioleiomyomatosis , 2019, International journal of cancer.

[25]  N. Kondo,et al.  Sirolimus treatment for recurrent lymphangioleiomyomatosis after lung transplantation. , 2009, The Annals of thoracic surgery.

[26]  R. Speich,et al.  Lung transplantation for lymphangioleiomyomatosis: the European experience. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[27]  H. Date,et al.  [Lung transplantation]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[28]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[29]  G. Amann,et al.  Recurrence of lymphangioleiomyomatosis after single lung transplantation: new insights into pathogenesis. , 2003, Human pathology.